New drug delivers promising survival gains in pancreatic cancer
About 90% of people with pancreatic cancer have pancreatic ductal adenocarcinoma (PDAC), which is driven by an activating mutation in…
AI reveals effective combination therapy for advanced rectal cancer
Artificial intelligence developed by researchers at UCL has revealed a promising combination of cancer treatments that could help…
Engineered probiotic bacteria boost immune attack against pancreatic cancer
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major…
TREM2 helps macrophages survive and repair radiation damaged skin
Recently, teams led by Prof. Yiming Zhang from Xinqiao Hospital, Army Medical University,Prof. Fazhi Qi from Zhongshan Hospital,…
Global analysis uses machine learning to map drivers of cancer outcomes
For the first time, researchers have used machine learning – a type of artificial intelligence (AI) – to…
New insights into glioblastoma survival linked to brain fluid dynamics
Glioblastoma-the most aggressive form of brain cancer-remains one of medicine’s biggest challenges. Despite surgery, radiotherapy, and chemotherapy, most…
New NIH grants fuel research in oral cancer treatment and pain relief
Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University…
Randomized trial finds both proton and photon therapies preserve post-treatment well-being
The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report…
Post-operative radiation therapy reduces pelvic relapse in high-risk bladder cancer
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive…
Proton therapy and IMRT show similar outcomes in head and neck cancer trial
A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in…
UCLA presents advances in radiation therapy at ASTRO 2025
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results…
Nuclide Therapeutics secures over $6 million for drugs against treatment-resistance cancers
Nuclide Therapeutics, a King’s College London spinout developing radioactive drugs to target therapy-resistant cancers, has closed a…